Remote effects of subcortical cerebrovascular lesions: a SPECT cerebral perfusion study.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 3260596)

Published in J Cereb Blood Flow Metab on August 01, 1988

Authors

D Perani1, V Di Piero, G Lucignani, M C Gilardi, P Pantano, C Rossetti, C Pozzilli, P Gerundini, F Fazio, G L Lenzi

Author Affiliations

1: Department of Biomedical Technology, University of Milan, Italy.

Articles by these authors

Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography: theory, procedure, and normal values. J Comput Assist Tomogr (1980) 4.94

Dyslexia: cultural diversity and biological unity. Science (2001) 4.17

Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage (2002) 3.88

Localization of grasp representations in humans by PET: 1. Observation versus execution. Exp Brain Res (1996) 2.80

Brain activity during observation of actions. Influence of action content and subject's strategy. Brain (1997) 2.73

A cultural effect on brain function. Nat Neurosci (2000) 2.69

Guidelines on use of anti-IFN-beta antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-beta antibodies in multiple sclerosis. Eur J Neurol (2005) 2.67

Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease. Arch Neurol (1998) 2.38

Physical performance of a positron tomograph for brain imaging with retractable septa. Phys Med Biol (1992) 2.27

Physical performance of the new hybrid PET∕CT Discovery-690. Med Phys (2011) 2.08

Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain (1981) 2.08

[Rapid increase of the use of PET in cancer investigation--but Sweden lags behind]. Lakartidningen (2000) 2.02

Mapping motor representations with positron emission tomography. Nature (1994) 2.00

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol (2011) 1.93

Cognitive and psychosocial features of childhood and juvenile MS. Neurology (2008) 1.85

Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. Neurology (2010) 1.85

Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment. Mult Scler (2005) 1.81

Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis. Neurology (2008) 1.80

Pulse monthly steroids during an elective interruption of natalizumab: a post-marketing study. Eur J Neurol (2011) 1.78

The bilingual brain. Proficiency and age of acquisition of the second language. Brain (1998) 1.75

The neural correlates of verb and noun processing. A PET study. Brain (1999) 1.71

Effects of thalamic stroke on energy metabolism of the cerebral cortex. A positron tomography study in man. Brain (1986) 1.70

Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus (1999) 1.70

Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone. Neurology (2011) 1.68

Unilateral neglect restricted to visual imagery. Nature (1993) 1.66

Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis. Neurology (1999) 1.65

Multiple sclerosis in childhood: clinical features of 149 cases. Mult Scler (1997) 1.65

Assessment of regional ventilation by continuous inhalation of radioactive krypton-81m. Br Med J (1975) 1.62

Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int (2001) 1.58

Crossed cerebellar diaschisis. Further studies. Brain (1986) 1.56

Brain abnormalities underlying altered activation in dyslexia: a voxel based morphometry study. Brain (2005) 1.55

Neutralizing antibodies during treatment of secondary progressive MS with interferon beta-1b. Neurology (2003) 1.54

Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS. Mult Scler (2007) 1.49

Local cerebral glucose utilization in controlled graded levels of hyperglycemia in the conscious rat. J Cereb Blood Flow Metab (1988) 1.49

Frontal lobe dysfunction in essential tremor: a preliminary study. J Neurol (2001) 1.49

Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping. Neuroimage (1999) 1.47

Double versus single stapling technique in rectal anastomosis. Int J Colorectal Dis (1992) 1.47

High prevalence of the thallium-201 reverse redistribution phenomenon in patients with syndrome X. Eur Heart J (1996) 1.47

Regional cerebral blood flow and oxygen consumption in human aging. Stroke (1984) 1.46

One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis. Eur J Neurol (2009) 1.46

Transcranial Doppler for brain death after decompressive craniectomy: persistence of cerebral blood flow with flat EEG. Intensive Care Med (2010) 1.44

Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis. Neurology (2010) 1.44

Positron emission tomography in neuronal ceroid lipofuscinosis (Jansky-Bielschowsky disease): a case report. Brain Dev (1995) 1.42

Aphasia and neglect after subcortical stroke. A clinical/cerebral perfusion correlation study. Brain (1987) 1.41

Current practice of brain death determination and use of confirmatory tests in an Italian University hospital: a report of 66 cases. Minerva Anestesiol (2013) 1.41

Hand weakness from a precentral gyrus infarct with intermittent hypotension. Neurology (2001) 1.39

Facts and figures on the QJNM&MI: a report by the outgoing editor. Q J Nucl Med Mol Imaging (2009) 1.39

A case-control study on Alzheimer's disease and exposure to anesthesia. Neurol Sci (2002) 1.38

Brain processing of native and foreign languages. Neuroreport (1996) 1.38

Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients. Cancer Res (1991) 1.38

Recovery from aphasia and neglect after subcortical stroke: neuropsychological and cerebral perfusion study. J Neurol Neurosurg Psychiatry (1988) 1.37

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis. Brain (2000) 1.35

Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials. Neurology (2004) 1.34

Interhemispheric transmission of visuomotor information in humans: fMRI evidence. J Neurophysiol (2002) 1.33

Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2). Neuromuscul Disord (2003) 1.33

Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography. J Urol (2003) 1.32

Prosopagnosia can be associated with damage confined to the right hemisphere--an MRI and PET study and a review of the literature. Neuropsychologia (1994) 1.31

Word and picture matching: a PET study of semantic category effects. Neuropsychologia (1999) 1.29

Syntax and the brain: disentangling grammar by selective anomalies. Neuroimage (2001) 1.29

Different brain correlates for watching real and virtual hand actions. Neuroimage (2001) 1.28

A fMRI study of word retrieval in aphasia. Brain Lang (2003) 1.27

Regional reductions of gray matter volume in familial dyslexia. Neurology (2004) 1.25

Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease. J Nucl Med (1988) 1.25

Image-based point spread function implementation in a fully 3D OSEM reconstruction algorithm for PET. Phys Med Biol (2010) 1.24

Progressing neurological deficit secondary to acute ischemic stroke. A study on predictability, pathogenesis, and prognosis. Arch Neurol (1995) 1.24

[18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Br J Psychiatry (1995) 1.23

Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence. Neurology (2008) 1.21

Acupuncture produces central activations in pain regions. Neuroimage (2001) 1.21

Neural basis of maternal communication and emotional expression processing during infant preverbal stage. Cereb Cortex (2008) 1.20

Left and right hemisphere contribution to recovery from neglect after right hemisphere damage--an [18F]FDG pet study of two cases. Neuropsychologia (1993) 1.20

A PET follow-up study of recovery after stroke in acute aphasics. Brain Lang (1997) 1.20

Crossed aphasia: a PET follow up study of two cases. J Neurol Neurosurg Psychiatry (1993) 1.19

Interictal habituation deficit of the nociceptive blink reflex: an endophenotypic marker for presymptomatic migraine? Brain (2007) 1.18

Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis. Neurology (1990) 1.17

Contrast carotid ultrasound for the detection of unstable plaques with neoangiogenesis: a pilot study. Eur J Vasc Endovasc Surg (2009) 1.15

Visual feedback has differential effects on reaching movements in Parkinson's and Alzheimer's disease. Brain Res (2000) 1.15

Functional heterogeneity of left inferior frontal cortex as revealed by fMRI. Neuroreport (1997) 1.15

Quantitative measurement of regional extravascular lung density using positron emission and transmission tomography. J Comput Assist Tomogr (1981) 1.15

Comparison of cerebral angiography and transcranial Doppler sonography in acute stroke. Stroke (1989) 1.14

Intrapancreatic accessory spleen mimicking a neuroendocrine tumor: magnetic resonance findings and possible diagnostic role of different nuclear medicine tests. Eur Radiol (2003) 1.14

Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci (1989) 1.14

Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome. J Neurol (1997) 1.12

Motor recovery after stroke. Morphological and functional brain alterations. Brain (1996) 1.12

Measurement of local cerebral blood flow with [14C]iodoantipyrine in the mouse. J Cereb Blood Flow Metab (1988) 1.10

Biodistribution of Tc-99m methoxy-isobutyl-isonitrile (MIBI) in humans. Eur J Nucl Med (1989) 1.10

Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dement Geriatr Cogn Disord (2000) 1.10